The FDA has approved Roche’s Susvimo (ranibizumab), a long-lasting injectable drug for treating people with “wet” age-related macular degeneration. Susvimo, which continuously delivers therapy via a refillable ocular implant, can be administered just twice a year, providing an alternative to…
Read MoreBy Dan Roberts – MDSupport.org “Tom”, a 73-year-old male, complained of severe dry eye syn- drome and loss of acuity after one injection of an anti-VEGF drug for treatment of wet macular degeneration. Tom had previously undergone four months of…
Read MorePhilip C Hessburg MD What are the indications for cataract surgery? In short: One should consider having cataracts removed when one’s vision has fallen to levels where he/she cannot do the things one needs – or wants – to do….
Read Moreby Dan RobertsMD Foundation Resource Director888-866-6148 Age-related macular degeneration (AMD) is a progressive disease of the retina wherein the light-sensing cells in the central area of vision (the macula) stop working and eventually die. The disease is thought to be…
Read MoreA report from the National Poll on Healthy Aging reveals that more than half of older patients surveyed said their primary care providers have not asked them about their vision. Considering the number of ailments that can affect the aging…
Read MoreWritten By: Kierstan Boyd Reviewed By: G Atma Vemulakonda, MD Jan. 27, 2019 Can you have cataract surgery to restore some clear vision if you have macular degeneration? Before recommending cataract surgery, your ophthalmologist will want to find out whether…
Read MoreAmerican Academy of Ophthalmology Written By: David Turbert and Dan T. Gudgel Reviewed By: Andrew George Iwach, MD Jan. 28, 2019 Cannabis and currently available compounds derived from marijuana – like CBD – are not an adequate treatment for glaucoma,…
Read MoreCalifornia companies lacked scientific evidence that their “amniotic stem cell therapy” could treat or cure macular degeneration and other serious diseases. A California-based physician and the two companies he controls have settled charges of deceptively advertising that “amniotic stem cell…
Read MoreScientists at the University of Birmingham are one step closer to developing an eye drop that could revolutionize treatment for wet age-related macular degeneration. The condition is currently treated by injections of anti-VEGF drugs into the eye. Drops have already…
Read MoreThe FDA has recently approved Luxturna, a new gene therapy developed by Spark Therapeutics, to treat an inherited form of vision loss that can result in blindness. The most prevalent inherited retinal dystrophies are retinitis pigmentosa (RP), Leber congenital amaurosis…
Read MoreSource: American Academy of Ophthalmology Millions of people who put up with seeing annoying specks drift through their field of vision may now have a safe, high-tech solution to their problem. A study of patients who had laser treatment to…
Read More